Clinical Trial Update: A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing lenalidomide to placebo in transfusion-dependent anemia in lower-risk myelodysplastic syndrome without del(5q) has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndrome

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Celgene | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2015-06-18